Lenvatinib Mesylate and Mycophenolate Tablets Delayed Release
Determining the interaction of Lenvatinib Mesylate and Mycophenolate Tablets Delayed Release and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: mycophenolic acid
Brand name: Myfortic
Synonyms: Mycophenolic acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Mycophenolic acid
- Lenvatinib Mesylate-Mycophenolic Acid Delayed-Release Tablets
- Lenvatinib Mesylate-Mycophenolic Acid Tablets
- Lenvatinib Mesylate-Mycostatin (Nystatin Oral Suspension)
- Lenvatinib Mesylate-Mycostatin (Nystatin Tablets and Capsules)
- Lenvatinib Mesylate-Mycostatin Suspension
- Mycophenolate Tablets Delayed Release-Lenvima
- Mycophenolate Tablets Delayed Release-Lenvima (14 MG Daily Dose)
- Mycophenolate Tablets Delayed Release-Lenvima (18 MG Daily Dose)
- Mycophenolate Tablets Delayed Release-Lenvima (20 MG Daily Dose)
- Mycophenolate Tablets Delayed Release-Lenvima (24 MG Daily Dose)
- Mycophenolate Tablets Delayed Release-Lenvima (8 MG Daily Dose)